Cancer

Clinical insights, innovative procedures, and tips for helping to prevent and treat cancer

  • Targeting cancer cells: Two studies take different approaches

    Targeting cancer cells: Two studies take different approaches

    A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

    Read Article
  • The evolution of cancer immunotherapy: Dr. Urba shares his insights

    The evolution of cancer immunotherapy: Dr. Urba shares his insights

    Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

    Read Article
  • Cancer survivorship: A guide to living with and beyond cancer

    Cancer survivorship: A guide to living with and beyond cancer

    June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

    Read Article
  • Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer

    Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer

    Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

    Read Article
  • Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3

    Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3

    The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.

    Read Article
  • With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

    With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

    A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

    Read Article
  • Covenant Health Earns APEx Accreditation for Radiation Oncology Services

    Covenant Health Earns APEx Accreditation for Radiation Oncology Services

    The radiation oncology team at Joe Arrington Cancer Center is awarded APEx Accreditation for excellent care.

    Read Article
  • Cancer studies seek to harness the power of the immune system

    Cancer studies seek to harness the power of the immune system

    Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

    Read Article
  • Providence Regional Cancer System Patient Navigator Focuses on Head and Neck Cancers

    Providence Regional Cancer System Patient Navigator Focuses on Head and Neck Cancers

    Patient Navigators provide a wealth of information and support to patients and families at all three Providence oncology locations: Lacey, Centralia and Aberdeen.

    Read Article
  • Providence Swedish advanced lung-cancer technology surpasses 500 patients served

    Providence Swedish advanced lung-cancer technology surpasses 500 patients served

    ​​​​​​​Ion robot-assisted bronchoscopy and Lung Nodule Clinic continue to ease patients’ way

    Read Article
  • Celebrating World Immunology Day

    Celebrating World Immunology Day

    Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

    Read Article
  • Two keys to good men’s health are prevention and detection

    Two keys to good men’s health are prevention and detection

    Providence Chief Medical Officer Dan Getz, D.O., focuses on prevention for men’s health, as well as early detection of cancer and other illness.

    Read Article
  • Knowledge is Power

    Knowledge is Power

    Genetic testing provides insight into inherited health risks.

    Read Article
  • The Ion Robot: Revolutionizing lung cancer diagnostics

    The Ion Robot: Revolutionizing lung cancer diagnostics

    Precision technology empowers early detection for improved patient outcomes

    Read Article
  • New vaccine being studied for HPV+ head and neck cancer

    New vaccine being studied for HPV+ head and neck cancer

    Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

    Read Article
  • Synergy at the Advanced Care Center

    Synergy at the Advanced Care Center

    With five specialty practices under one roof, patients experience optimal care with maximum convenience at the Providence Advanced Care Center.

    Read Article
  • Celebrating our oncology social workers

    Celebrating our oncology social workers

    In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

    Read Article
  • Providence Alaska to host colorectal cancer awareness event March 26

    Providence Alaska to host colorectal cancer awareness event March 26

    The Providence Cancer Center is hosting an event to help raise awareness about colorectal cancer 11 a.m.-1 p.m. Tuesday, March 26, in the Providence Health Park.

    Read Article
  • Talking to an expert: The crucial role of nutrition in cancer care

    Talking to an expert: The crucial role of nutrition in cancer care

    In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

    Read Article
  • How promoting apoptosis in new study may help people with cancer

    How promoting apoptosis in new study may help people with cancer

    In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

    Read Article
  • loading
    Loading More...